[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Intercept Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intercept Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Recro Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Recro Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aptevo Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aptevo Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Sesen Bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sesen Bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

NanoString Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NanoString Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

SCYNEXIS, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SCYNEXIS, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

vTv Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

vTv Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Argos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Argos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

INC Research Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

INC Research Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Proteostasis Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proteostasis Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

TRACON Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TRACON Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Corbus Pharmaceuticals Holding Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Corbus Pharmaceuticals Holding Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Enanta Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Enanta Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Epizyme Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Epizyme Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AC Immune Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AC Immune Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Veracyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Veracyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Horizon Pharma PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Horizon Pharma PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Retrophin Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Retrophin Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Supernus Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Supernus Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Adaptimmune Therapeutics Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adaptimmune Therapeutics Plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Clearside Biomedical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clearside Biomedical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Organovo Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Organovo Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

CytomX Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CytomX Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Insys Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Insys Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Miragen Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Miragen Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Onconova Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Onconova Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AcelRx Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AcelRx Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Alder BioPharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alder BioPharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ChemoCentryx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ChemoCentryx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Fate Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fate Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Nabriva Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nabriva Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Neos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

OncoMed Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoMed Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

TG Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TG Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ADMA Biologics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ADMA Biologics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Altimmune Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Altimmune Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Chimerix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chimerix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

EyeGate Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

EyeGate Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Tocagen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tocagen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Dermira, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dermira, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ENDRA Life Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ENDRA Life Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Regenxbio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenxbio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Capricor Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capricor Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Concert Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Concert Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Novocure Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novocure Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Syndax Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Syndax Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aduro Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aduro Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bellicum Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bellicum Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

FibroGen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

FibroGen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ocular Therapeutix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocular Therapeutix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers